These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29370923)

  • 1. The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function.
    Alaswad K; Basir MB; Khandelwal A; Schreiber T; Lombardi W; O'Neill W
    Am J Cardiol; 2018 Mar; 121(6):703-708. PubMed ID: 29370923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Alraies MC; Kaki A; Kajy M; Blank N; Hasan R; Htun WW; Glazier JJ; Elder M; O'Neill WW; Grines CL; Schreiber T
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):536-544. PubMed ID: 31631515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of rotational atherectomy in patients with severe left ventricular dysfunction without hemodynamic support.
    Whiteside HL; Ratanapo S; Nagabandi A; Kapoor D
    Cardiovasc Revasc Med; 2018 Sep; 19(6):660-665. PubMed ID: 29525558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
    Shavelle DM; Banerjee S; Maini B; Schreiber TL; Kapasi N; O'Neill WW; Popma J; Matthews RV
    Am J Cardiol; 2018 Sep; 122(6):966-972. PubMed ID: 30057231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention.
    Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y
    BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital outcomes after rotational atherectomy in patients with low ejection fraction.
    Watanabe Y; Naganuma T; Kawamoto H; Ishiguro H; Nakamura S
    Scand Cardiovasc J; 2018 Aug; 52(4):177-182. PubMed ID: 29668339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Cohen MG; Matthews R; Maini B; Dixon S; Vetrovec G; Wohns D; Palacios I; Popma J; Ohman EM; Schreiber T; O'Neill WW
    Am Heart J; 2015 Nov; 170(5):872-9. PubMed ID: 26542494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Riley RF; McCabe JM; Kalra S; Lazkani M; Pershad A; Doshi D; Kirtane AJ; Nicholson W; Kearney K; Demartini T; Aaron Grantham J; Moses J; Lombardi W; Karmpaliotis D
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1261-1267. PubMed ID: 30019817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
    Al-Husami W; Yturralde F; Mohanty G; Pastore C; Lotun K; Venesy D; Waxman S; Pyne C; Gossman D; Nesto R; Piemonte T
    J Invasive Cardiol; 2008 Jun; 20(6):319-22. PubMed ID: 18523330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in left ventricular function after a percutaneous coronary intervention: prevalence, predictors, and prognosis.
    Levi A; Bental T; Assali AR; Lev EI; Vaknin Assa H; Shaul AA; Sagie A; Kornowski R
    Coron Artery Dis; 2016 May; 27(3):199-206. PubMed ID: 26848535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Al-Khadra Y; Alraies MC; Darmoch F; Pacha HM; Soud M; Kaki A; Rab T; Grines CL; Meraj P; Alaswad K; Kwok CS; Mamas M; Kapadia S
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):503-512. PubMed ID: 31254325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotational Atherectomy for Severely Calcified Lesions in Patients With Left Ventricular Systolic Dysfunction: One-Year Outcomes From aSingle-Center Registry Analysis.
    Yoshida R; Ishii H; Morishima I; Tanaka A; Takagi K; Yoshioka N; Morita Y; Unno K; Yoshida Y; Tsuboi H; Murohara T
    Cardiovasc Revasc Med; 2020 Oct; 21(10):1220-1227. PubMed ID: 32457019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.